BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10194127)

  • 1. Suppression of growth and dissemination in human pre-B leukemia cells by tumor necrosis factor-alpha in scid mice.
    Yoshida N; Ishii E; Mohri S; Nagumo F; Yoshidomi S; Miyazaki S
    Leuk Lymphoma; 1999 Mar; 33(1-2):107-18. PubMed ID: 10194127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor formation by a human pre-B leukemia cell line in scid mice is enhanced by matrigel and is associated with induction of CD10 expression.
    Ishii E; Greaves A; Grunberger T; Freedman MH; Letarte M
    Leukemia; 1995 Jan; 9(1):175-84. PubMed ID: 7845014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The laminin-derived peptide YIGSR (Tyr-Ile-Gly-Ser-Arg) inhibits human pre-B leukaemic cell growth and dissemination to organs in SCID mice.
    Yoshida N; Ishii E; Nomizu M; Yamada Y; Mohri S; Kinukawa N; Matsuzaki A; Oshima K; Hara T; Miyazaki S
    Br J Cancer; 1999 Aug; 80(12):1898-904. PubMed ID: 10471037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The induction of CD10 on a pre-B leukemia cell line occurs with progression of the disease in scid mice.
    Ishii E; Greaves A; Grunberger T; Freedman MH; Letarte M
    Leukemia; 1993 Oct; 7(10):1592-601. PubMed ID: 7692193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential kinetics of engraftment and induction of CD10 on human pre-B leukemia cell lines in immune deficient scid mice.
    Kamel-Reid S; Dick JE; Greaves A; Murdoch B; Doedens M; Grunberger T; Thorner P; Freedman MH; Phillips RA; Letarte M
    Leukemia; 1992 Jan; 6(1):8-17. PubMed ID: 1531243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human t(1;19)(q23;p13) pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency.
    Uckun FM; Downing JR; Gunther R; Chelstrom LM; Finnegan D; Land VJ; Borowitz MJ; Carroll AJ; Crist WM
    Blood; 1993 Jun; 81(11):3052-62. PubMed ID: 8098968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Good engraftment of B-cell precursor ALL in NOD-SCID mice.
    Baersch G; Möllers T; Hötte A; Dockhorn-Dworniczak B; Rübe C; Ritter J; Jürgens H; Vormoor J
    Klin Padiatr; 1997; 209(4):178-85. PubMed ID: 9293448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF-alpha regulates mouse fetal hepatic maturation induced by oncostatin M and extracellular matrices.
    Kamiya A; Gonzalez FJ
    Hepatology; 2004 Sep; 40(3):527-36. PubMed ID: 15349890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNFR80-dependent enhancement of TNFR60-induced cell death is mediated by TNFR-associated factor 2 and is specific for TNFR60.
    Weiss T; Grell M; Siemienski K; Mühlenbeck F; Dürkop H; Pfizenmaier K; Scheurich P; Wajant H
    J Immunol; 1998 Sep; 161(6):3136-42. PubMed ID: 9743381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice.
    Weimar IS; Weijer K; van den Berk PC; Muller EJ; Miranda N; Bakker AQ; Heemskerk MH; Hekman A; de Gast GC; Gerritsen WR
    Br J Cancer; 1999 Sep; 81(1):43-53. PubMed ID: 10487611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VLA-4 is involved in the engraftment of the human pre-B acute lymphoblastic leukaemia cell line NALM-6 in SCID mice.
    Filshie R; Gottlieb D; Bradstock K
    Br J Haematol; 1998 Sep; 102(5):1292-300. PubMed ID: 9753059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoglin is a component of the transforming growth factor (TGF)-beta receptor complex of human pre-B leukemic cells.
    Zhang H; Shaw AR; Mak A; Letarte M
    J Immunol; 1996 Jan; 156(2):564-73. PubMed ID: 8543807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Matrigel and laminin peptide YIGSR on tumor growth and metastasis.
    Yamamura K; Kibbey MC; Jun SH; Kleinman HK
    Semin Cancer Biol; 1993 Aug; 4(4):259-65. PubMed ID: 8400148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct in vivo engraftment and growth patterns of t(1;19)+/E2A-PBX1+ and t(9;22)+/BCR-ABL+ human leukemia cells in SCID mice.
    Waurzyniak BJ; Heerema N; Sensel MG; Gaynon PS; Kraft P; Sather HN; Chelstrom L; Reaman GH; Uckun FM
    Leuk Lymphoma; 1998 Dec; 32(1-2):77-87. PubMed ID: 10037003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of tumor necrosis factor-alpha on the proliferation of leukemic cells from children with B-cell precursor-acute lymphoblastic leukemia (BCP-ALL): studies of primary leukemic cells and BCP-ALL cell lines.
    Zhou MX; Findley HW; Ma LH; Zaki SR; Hill T; Hamid M; Hooper WC; Ragab AH
    Blood; 1991 May; 77(9):2002-7. PubMed ID: 2018837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF-alpha-induced growth suppression of CD34+ myeloid leukemic cell lines signals through TNF receptor type I and is associated with NF-kappa B activation.
    Hu X; Tang M; Fisher AB; Olashaw N; Zuckerman KS
    J Immunol; 1999 Sep; 163(6):3106-15. PubMed ID: 10477576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two serologic markers to monitor the engraftment, growth, and treatment response of human leukemias in severe combined immunodeficient mice.
    Arguello F; Sterry JA; Zhao YZ; Alexander MR; Shoemaker RH; Cohen HJ
    Blood; 1996 May; 87(10):4325-32. PubMed ID: 8639792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced tumor growth of both primary and established human and murine tumor cells in athymic mice after coinjection with Matrigel.
    Fridman R; Kibbey MC; Royce LS; Zain M; Sweeney M; Jicha DL; Yannelli JR; Martin GR; Kleinman HK
    J Natl Cancer Inst; 1991 Jun; 83(11):769-74. PubMed ID: 1789823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined effect of interferon-gamma and tumor necrosis factor-alpha causing suppression of leukemic blast progenitors in acute myeloblastic leukemia.
    Nara N
    Leuk Lymphoma; 1993 Jun; 10(3):201-7. PubMed ID: 7693101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and functional role of tumor necrosis factor receptors on leukemic cells from patients with type B chronic lymphoproliferative disorders.
    Trentin L; Zambello R; Agostini C; Siviero F; Adami F; Marcolongo R; Raimondi R; Chisesi T; Pizzolo G; Semenzato G
    Blood; 1993 Feb; 81(3):752-8. PubMed ID: 8381309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.